
    
      This randomized, two-period crossover study will include one screening/baseline visit (visit
      1) and two 24-h treatment periods (treatment period 1: visits 2 and 3 and treatment period 2:
      visits 4 and 5). A minimum 7-d washout will occur between the treatment periods.
    
  